Pages that link to "Q41313971"

The following pages link to Effect of surgical debulking on survival in stage IV ovarian cancer (Q41313971):

Displaying 30 items.

• Surgical management of ovarian cancer (Q33742791) (← links)
• Up date in the management of advanced ovarian carcinoma (Q33787474) (← links)
• Maximal cytoreductive effort in epithelial ovarian cancer surgery (Q33955721) (← links)
• Cytoreductive surgery for advanced stages of ovarian cancer (Q33959827) (← links)
• Drug therapy for gynaecological cancer in older women (Q33996151) (← links)
• Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy (Q34315086) (← links)
• Cytoreductive surgery for ovarian cancer (Q34364743) (← links)
• Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients (Q35475560) (← links)
• The role of interval debulking surgery in ovarian cancer (Q35548344) (← links)
• The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma (Q36052380) (← links)
• The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions (Q36675641) (← links)
• Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review (Q37432638) (← links)
• Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease. (Q37988243) (← links)
• Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer (Q38682323) (← links)
• Trends in Mortality After Primary Cytoreductive Surgery for Ovarian Cancer: A Systematic Review and Metaregression of Randomized Clinical Trials and Observational Studies (Q39023165) (← links)
• Progress in ovarian cancer (Q41713671) (← links)
• Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? (Q43204758) (← links)
• Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective (Q43852073) (← links)
• Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5. (Q43992111) (← links)
• Hepatic resection for metachronous metastases from ovarian carcinoma (Q44359509) (← links)
• Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction? (Q45014116) (← links)
• Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients (Q45194081) (← links)
• Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer (Q46317510) (← links)
• Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study (Q46869580) (← links)
• Relevance of enlarged cardiophrenic lymph nodes in determining prognosis of patients with advanced ovarian cancer (Q48248709) (← links)
• The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions (Q48860180) (← links)
• Advanced ovarian cancer (Q74267103) (← links)
• Epithelial ovarian cancer (Q77924565) (← links)
• Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers (Q88302050) (← links)
• Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study (Q98463162) (← links)